Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

TOR, a Central Controller of Cell Growth

Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,914

Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway

Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555

Regulation of translation initiation by FRAP/mTOR

Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545

Amino Acid Sufficiency and mTOR Regulate p70 S6 Kinase and eIF-4E BP1 through a Common Effector Mechanism

Hara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., BELHAM, C. M., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,370

Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases

Chung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,151

Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E

Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093

Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap

Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 971

Mammalian TOR: a homeostatic ATP sensor

Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., & Thomas, G. (2001) · Science · doi:10.1126/science.1063518 · Cited by 962

A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells

Kwiatkowski, D. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.525 · Cited by 674

The mRNA 5′ cap-binding protein eIF4E and control of cell growth

Sonenberg, N., & Gingras, A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80150-6 · Cited by 673

Ridaforolimus (AP23573; MK-8669), a Potent mTOR Inhibitor, Has Broad Antitumor Activity and Can Be Optimally Administered Using Intermittent Dosing Regimens

Rivera, V. M., Squillace, R. M., Miller, D., Berk, L., Wardwell, S., Ning, Y., Pollock, R. M., Narasimhan, N. I., Iuliucci, J. D., Wang, F., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0792 · Cited by 107

mTOR at the crossroads of T cell proliferation and tolerance

Mondino, A., & Mueller, D. L. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.02.008 · Cited by 107

p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma

Luo, Y., Fang, L., Yu, H., Zhang, J., Lin, X., Liu, X., Wu, D., Li, G.-X., Deng, H., Zhang, Y., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.036 · Cited by 105

Unusually mild tuberous sclerosis phenotype is associated withTSC2R905Q mutation

Jansen, A., Sancak, Ő., D’Agostino, D., Badhwar, A., Roberts, P. S., Gobbi, G., Wilkinson, R. D., Melanson, D., Tampieri, D. I., Koenekoop, R. K., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21037 · Cited by 105

Autophagy and polyglutamine diseases

Jiménez-Sánchez, M., Thomson, F., Zavodszky, E., & Rubinsztein, D. C. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.013 · Cited by 105

Neuronal Autophagy and Neurodevelopmental Disorders

Lee, K., Hwang, S.-K., & Lee, J. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.3.133 · Cited by 101

mTOR: A placental growth signaling sensor

Wen, H. Y., Abbasi, S., Kellems, R. E., & Xia, Y. (2005) · Placenta · doi:10.1016/j.placenta.2005.02.004 · Cited by 102

PTEN Represses RNA Polymerase I Transcription by Disrupting the SL1 Complex

Zhang, C., Comai, L., & Johnson, D. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.6899-6911.2005 · Cited by 101

Pathogenetic mechanisms of focal cortical dysplasia

Marin‐Valencia, I., Guerrini, R., & Gleeson, J. G. (2014) · Epilepsia · doi:10.1111/epi.12650 · Cited by 100

Tuberous sclerosis: a review of the past, present, and future

Uysal, S. P., & Şahin, M. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2002-133 · Cited by 108

Molecular Pathogenesis of Tuber Formation in Tuberous Sclerosis Complex

Crino, P. B. (2004) · Journal of Child Neurology · doi:10.1177/08830738040190091301 · Cited by 100

Molecular mechanisms through which amino acids mediate signaling through the mammalian target of rapamycin

Kimball, S. R., & Jefferson, L. S. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200401000-00008 · Cited by 99

AMP‐activated protein kinase: a core signalling pathway in the heart

Kim, A. S., Miller, E. J., & Young, L. H. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01978.x · Cited by 99

Role of Adipokines Signaling in the Modulation of T Cells Function

Procaccini, C., Rosa, V. D., Galgani, M., Carbone, F., Rocca, C. L., Formisano, L., & Matarese, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00332 · Cited by 103

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

Jühling, F., Hamdane, N., Crouchet, É., Shen, L., Saghire, H. E., Mukherji, A., Fujiwara, N., Oudot, M. A., Thumann, C., Saviano, A., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318918 · Cited by 102

PTEN Represses RNA Polymerase III-Dependent Transcription by Targeting the TFIIIB Complex

Woiwode, A., Johnson, S. A. S., Zhong, S., Zhang, C., Roeder, R. G., Teichmann, M., & Johnson, D. L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01912-07 · Cited by 104

Autophagy Negatively Regulates Early Axon Growth in Cortical Neurons

Ban, B.-K., Jun, M.-H., Ryu, H.-H., Jang, D., Ahmad, S. T., & Lee, J. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00627-13 · Cited by 101

Nutrient Signaling Components Controlling Protein Synthesis in Striated Muscle ,

Vary, T. C., & Lynch, C. J. (2007) · Journal of Nutrition · doi:10.1093/jn/137.8.1835 · Cited by 96

Time course changes in signaling pathways and protein synthesis in C2C12myotubes following AMPK activation by AICAR

Williamson, D. L., Bolster, D. R., Kimball, S. R., & Jefferson, L. S. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00566.2005 · Cited by 100

Exercise‐induced alterations in extracellular signal‐regulated kinase 1/2 and mammalian target of rapamycin (mTOR) signalling to regulatory mechanisms of mRNA translation in mouse muscle

Williamson, D. L., Kubica, N., Kimball, S. R., & Jefferson, L. S. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103481 · Cited by 96

ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway

Kuo, H.-P., Lee, D., Chen, C., Liu, M., Chou, C., Lee, H.-J., Du, Y., Xie, X., Wei, Y., Xia, W., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2000590 · Cited by 98

Genome‐wide DNA methylation analysis in alcohol dependence

Zhang, R., Miao, Q., Wang, C., Zhao, R., Li, W., Haile, C. N., Hao, W., & Zhang, X. Y. (2013) · Addiction Biology · doi:10.1111/adb.12037 · Cited by 93

PHLPP-Mediated Dephosphorylation of S6K1 Inhibits Protein Translation and Cell Growth

Liu, J., Stevens, P. D., Li, X., Schmidt, M. D., & Gao, T. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05799-11 · Cited by 98

A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits

Feliciano, D. M., Lin, T. V., Hartman, N. W., Bartley, C. M., Kubera, C., Hsieh, L. S., Lafourcade, C., O’Keefe, R. A., & Bordey, A. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.02.008 · Cited by 95

The mTOR Signaling Pathway in the Brain: Focus on Epilepsy and Epileptogenesis

Russo, E., Citraro, R., Constanti, A., & Sarro, G. D. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8314-5 · Cited by 91

Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with Tuberous Sclerosis Complex

Hoogeveen‐Westerveld, M., Wentink, M. W. J., van den Heuvel, D., Mozaffari, M., Ekong, R., Povey, S., den Dunnen, J. T., Metcalfe, K., Vallee, S. E., Krueger, S., et al. (2011) · Human Mutation · doi:10.1002/humu.21451 · Cited by 91

Molecular Neuropathology of Epilepsy-Associated Glioneuronal Malformations

Becker, A. J., Blümcke, I., Urbach, H., Hans, V., & Majores, M. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000199570.19344.33 · Cited by 90

Death‐associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death

Lin, Y., Hupp, T. R., & Stevens, C. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07411.x · Cited by 90

Roles for neuronal and glial autophagy in synaptic pruning during development

Lieberman, O. J., McGuirt, A. F., Tang, G., & Sulzer, D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.017 · Cited by 87

Interactive Roles for AMPK and Glycogen from Cellular Energy Sensing to Exercise Metabolism

Janzen, N. R., Whitfield, J., & Hoffman, N. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113344 · Cited by 88

Structural Basis for the Unique Biological Function of Small GTPase RHEB

Yu, Y., Li, S., Xu, X., Li, Y., Guan, K., Arnold, E., & Ding, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501253200 · Cited by 89

Postgenomic global analysis of translational control induced by oncogenic signaling

Rajasekhar, V. K., & Holland, E. C. (2004) · Oncogene · doi:10.1038/sj.onc.1207546 · Cited by 90

Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes

Lodish, M. B., & Stratakis, C. A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.02.002 · Cited by 89

Cross-talk between IGF-I and TGF-β signaling pathways

Danielpour, D., & SONG, K. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.007 · Cited by 91

Tuberous sclerosis complex

Islam, M. P., & Roach, E. S. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62702-5.00006-8 · Cited by 89

Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations

Miklja, Z., Pasternak, A. L., Stallard, S., Nicolaides, T. P., Kline-Nunnally, C., Cole, B., Beroukhim, R., Bandopadhayay, P., Chi, S. N., Ramkissoon, S. H., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz022 · Cited by 90

mTOR signaling contributes to chondrocyte differentiation

Phornphutkul, C., Wu, K., Auyeung, V., Chen, Q., & Gruppuso, P. A. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21464 · Cited by 88

Airway Smooth Muscle in Asthma

Hershenson, M. B., Brown, M. L., Camoretti-Mercado, B., & Solway, J. (2004) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.1.110304.100213 · Cited by 91

Endotoxin disrupts the leucine‐signaling pathway involving phosphorylation of mTOR, 4E‐BP1, and S6K1 in skeletal muscle

Lang, C. H., & Frost, R. A. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20207 · Cited by 88

Non‐canonical functions of the tuberous sclerosis complex‐Rheb signalling axis

Neuman, N. A., & Henske, E. P. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100131 · Cited by 87

Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes

Marx, S. J., & Simonds, W. F. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0037 · Cited by 87

Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy

Lazarowski, A., Lubieniecki, F. J., Camarero, S., Pomata, H. H., Bartuluchi, M., Sevlever, G. E., & Taratuto, A. L. (2004) · Pediatric Neurology · doi:10.1016/s0887-8994(03)00407-7 · Cited by 86

Regulation of T‐cell survival and mitochondrial homeostasis by TSC1

O'Brien, T. F., Gorentla, B. K., Xie, D., Srivatsan, S., McLeod, I. X., He, Y.-W., & Zhong, X. (2011) · European Journal of Immunology · doi:10.1002/eji.201141411 · Cited by 89

KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops

Eibl, G., & Rozengurt, E. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.007 · Cited by 88

Amino acids as regulators of gene expression

Kimball, S. R., & Jefferson, L. S. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-3 · Cited by 88

Overcoming mTOR inhibition-induced paradoxical activation of survival signaling pathways enhances mTOR inhibitors’ anticancer efficacy

Wang, X., Hawk, N. N., Yue, P., Kauh, J. S. W., Ramalingam, S. S., Fu, H., Khuri, F. R., & Sun, S. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.12.6944 · Cited by 84

Phosphorylation of Tuberin as a Novel Mechanism for Somatic Inactivation of the Tuberous Sclerosis Complex Proteins in Brain Lesions

Han, S., Santos, T. M., Puga, A. C., Roy, J., Thiele, E. A., McCollin, M., Stemmer-Rachamimov, A. O., & Ramesh, V. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3277 · Cited by 84

A novel cardioprotective p38-MAPK/mTOR pathway

Hernández, G., Lal, H., Fidalgo, M., Guerrero, A. T. G., Zalvide, J. B., Force, T. L., & Pombo, C. M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.09.011 · Cited by 88

Hereditary pancreatic endocrine tumours

Alexakis, N., Connor, S. J., Ghaneh, P., Lombard, M., Smart, H. L., Evans, J. D., Hughes, M., Garvey, C. J., Vora, J. P., Vinjamuri, S., et al. (2004) · Pancreatology · doi:10.1159/000079616 · Cited by 83

Association of Focal Adhesion Kinase with Tuberous Sclerosis Complex 2 in the Regulation of S6 Kinase Activation and Cell Growth

Gan, B., Yoo, Y., & Guan, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605241200 · Cited by 84

PDK4 Protein Promotes Tumorigenesis through Activation of cAMP-response Element-binding Protein (CREB)-Ras Homolog Enriched in Brain (RHEB)-mTORC1 Signaling Cascade

Liu, Z., Chen, X., Wang, Y., Peng, H., Wang, Y., Jing, Y., & Zhang, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.584821 · Cited by 82

Regulation of Leucine Uptake by tor1+ in Schizosaccharomyces pombe Is Sensitive to Rapamycin

Weisman, R., Roitburg, I., Nahari, T., & Kupiec, M. (2004) · Genetics · doi:10.1534/genetics.104.034983 · Cited by 81

Follicle-Stimulating Hormone Inhibits Adenosine 5′-Monophosphate-Activated Protein Kinase Activation and Promotes Cell Proliferation of Primary Granulosa Cells in Culture through an Akt-Dependent Pathway

Kayampilly, P. P., & Menon, K. M. J. (2008) · Endocrinology · doi:10.1210/en.2008-1032 · Cited by 89

Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway

Winter, J. N., Fox, T. E., KESTER, M. A., Jefferson, L. S., & Kimball, S. R. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00039.2010 · Cited by 84

Pam and Its Ortholog Highwire Interact with and May Negatively Regulate the TSC1·TSC2 Complex

Murthy, V., Han, S., Beauchamp, R. L., Smith, N., Haddad, L. A., Ito, N., & Ramesh, V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310208200 · Cited by 82

Peptide Combinatorial Libraries Identify TSC2 as a Death-associated Protein Kinase (DAPK) Death Domain-binding Protein and Reveal a Stimulatory Role for DAPK in mTORC1 Signaling

Stevens, C., Lin, Y., Harrison, B. J., Burch, L. R., Ridgway, R. A., Sansom, O. J., & Hupp, T. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805165200 · Cited by 82

Cracking the EGFR code: Cancer biology, resistance mechanisms, and future therapeutic frontiers

Du, Y.-F., Karatekin, F., Wang, W. K., Hong, W., & Gandhi, T. K. B. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100076 · Cited by 88

Distinct effects of single amino-acid changes to tuberin on the function of the tuberin–hamartin complex

Nellist, M. D., Sancak, Ő., Goedbloed, M., Rohé, C. F., van Netten, D., Mayer, K., Williams, A. T., van den Ouweland, A. M. W., & Halley, D. J. J. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201276 · Cited by 81

Progesterone receptor membrane component 1/Sigma-2 receptor associates with MAP1LC3B and promotes autophagy

Mir, S. U., Schwarze, S. R., Jin, L., Zhang, J., Friend, W., Miriyala, S., St Clair, D., & Craven, R. J. (2013) · Autophagy · doi:10.4161/auto.25889 · Cited by 69

Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline

Brennesvik, E. O., Ktori, C., Ruzzin, J., Jebens, E., Shepherd, P. R., & Jensen, J. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.011 · Cited by 84

mTOR Signaling Confers Resistance to Targeted Cancer Drugs

Guri, Y., & Hall, M. N. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.10.006 · Cited by 81

mTOR and MAPK: from localized translation control to epilepsy

Pernice, H. F., Schieweck, R., Kiebler, M. A., & Popper, B. (2016) · BMC Neuroscience · doi:10.1186/s12868-016-0308-1 · Cited by 81

Immunoendocrine Dysregulation during Gestational Diabetes Mellitus: The Central Role of the Placenta

Olmos‐Ortiz, A., Flores‐Espinosa, P., Dı́az, L., Velázquez, P., Ramírez-Isarraraz, C., & Zaga‐Clavellina, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158087 · Cited by 81

Genetic Variability of the mTOR Pathway and Prostate Cancer Risk in the European Prospective Investigation on Cancer (EPIC)

Campa, D., Hüsing, A., Stein, A., Dostal, L., Boeing, H., Pischon, T., Tjønneland, A. M., Roswall, N., Overvad, K., Østergaard, J. N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016914 · Cited by 79

Amino Acids as Regulators of Gene Expression at the Level of mRNA Translation

Jefferson, L. S., & Kimball, S. R. (2003) · Journal of Nutrition · doi:10.1093/jn/133.6.2046s · Cited by 78

Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cells.

Zhou, C., Gehrig, P. A., Whang, Y. E., & Boggess, J. F. (2003) · PubMed · Cited by 78

TSC1 Activates TGF-β-Smad2/3 Signaling in Growth Arrest and Epithelial-to-Mesenchymal Transition

Thien, A., Prentzell, M. T., Holzwarth, B., Kläsener, K., Kuper, I., Boehlke, C. S., Sonntag, A., Ruf, S., Maerz, L. D., Nitschke, R., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.026 · Cited by 79

Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis

McDaniel, S. S., & Wong, M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.037 · Cited by 78

Metabolic Networks Influencing Skeletal Muscle Fiber Composition

Bourdeau‐Julien, I., Sephton, C. F., & Dutchak, P. A. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00125 · Cited by 83

Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.

Lin, F., Zhang, P. L., Yang, X. J., Prichard, J. W., Lun, M., & Brown, R. E. (2006) · PubMed · Cited by 74

The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex

Tee, A. R., Sampson, J. R., Pal, D. K., & Bateman, J. M. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.01.040 · Cited by 75

The Target of Rapamycin and Mechanisms of Cell Growth

Tee, A. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030880 · Cited by 75

The role of the TOR pathway in mediating the link between nutrition and longevity

Lushchak, O., Strilbytska, O., Piskovatska, V., Storey, K. B., Koliada, A., & Vaiserman, A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.03.005 · Cited by 73

Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation

Uhlmann, E. J., Li, W., Scheidenhelm, D. K., Gau, C., Tamanoi, F., & Gutmann, D. H. (2004) · Glia · doi:10.1002/glia.20036 · Cited by 72

Molecular Pathogenesis of Focal Cortical Dysplasia and Hemimegalencephaly

Crino, P. B. (2005) · Journal of Child Neurology · doi:10.1177/08830738050200041101 · Cited by 70

mTOR Signaling in Cancer Cell Motility and Tumor Metastasis

Zhou, H., & Huang, S. (2010) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i1.10 · Cited by 70

A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-κB regulates head and neck squamous cell carcinoma proliferation

Li, Z., Yang, Z., Passaniti, A., Lapidus, R. G., Liu, X., Cullen, K. J., & Dan, H. C. (2016) · Oncotarget · doi:10.18632/oncotarget.7441 · Cited by 70

Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid

Kam, Y., & Exton, J. H. (2004) · The FASEB Journal · doi:10.1096/fj.03-0731com · Cited by 72

Negative Regulation of TSC1-TSC2 by Mammalian D-Type Cyclins

Zacharek, S. J., Xiong, Y., & Shumway, S. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2236 · Cited by 72

From genes to cognition in tuberous sclerosis: Implications for mTOR inhibitor-based treatment approaches

Ehninger, D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.015 · Cited by 68

Mammalian Target of Rapamycin and Protein Kinase A Signaling Mediate the Cardiac Transcriptional Response to Glutamine*

Xia, Y., Wen, H., Young, M., Guthrie, P. H., Taegtmeyer, H., & Kellems, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208500200 · Cited by 69

TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium

Zhou, Y., Rychahou, P. G., Wang, Q., Weiss, H. L., & Evers, B. M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.588 · Cited by 72

The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: An overview

Crowell, J. A. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.016 · Cited by 69

Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo

Parisi, F., Riccardo, S., Daniel, M., Saqcena, M., Kundu, N., Pession, A., Grifoni, D., Stocker, H., Tabak, E. G., & Bellosta, P. (2011) · BMC Biology · doi:10.1186/1741-7007-9-65 · Cited by 72

IGF-1 stimulates protein synthesis by enhanced signaling through mTORC1 in bovine mammary epithelial cells

Burgos, S. A., & Cant, J. P. (2009) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2009.10.005 · Cited by 69

CD28 Regulates the Translation of Bcl-xL via the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Pathway

Wu, L., Rose, J. L., Chen, L., Neale, C., Mak, T. W., Okkenhaug, K., Wange, R. L., & Rottapel, R. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.180 · Cited by 68

Achieving specificity in Akt signaling in cancer

Toker, A. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.09.020 · Cited by 70

NOX4 Pathway as a Source of Selective Insulin Resistance and Responsiveness

Wu, X., & Williams, K. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.244525 · Cited by 67

Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components

Bahar, E., Han, S., Kim, J., & Yoon, H. (2022) · Cancers · doi:10.3390/cancers14061462 · Cited by 67

The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes

Xie, J., & Herbert, T. P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0874-4 · Cited by 69

Autism spectrum disorder: prospects for treatment using gene therapy

Benger, M., Kinali, M., & Mazarakis, N. D. (2018) · Molecular Autism · doi:10.1186/s13229-018-0222-8 · Cited by 67

Follicle-Stimulating Hormone Increases Tuberin Phosphorylation and Mammalian Target of Rapamycin Signaling through an Extracellular Signal-Regulated Kinase-Dependent Pathway in Rat Granulosa Cells

Kayampilly, P. P., & Menon, K. M. J. (2007) · Endocrinology · doi:10.1210/en.2007-0202 · Cited by 65

IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes

Duré, M., & Macián, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.029 · Cited by 65

Perspective: The Potential Role of Essential Amino Acids and the Mechanistic Target of Rapamycin Complex 1 (mTORC1) Pathway in the Pathogenesis of Child Stunting

Semba, R. D., Trehan, I., González‐Freire, M., Kraemer, K., Moaddel, R., Ordiz, M. I., Ferrucci, L., & MANARY, M. J. (2016) · Advances in Nutrition · doi:10.3945/an.116.013276 · Cited by 74

The role of mTOR in ovarian Neoplasms, polycystic ovary syndrome, and ovarian aging

Liu, J., Wu, D., Qu, L., Liao, H., & Li, M. (2018) · Clinical Anatomy · doi:10.1002/ca.23211 · Cited by 64

The Natural History and Treatment of Epilepsy in a Murine Model of Tuberous Sclerosis

Altay, E. E., Zeng, L., Xu, L., Gutmann, D. H., & Wong, M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01110.x · Cited by 64

Critical role of SCD1 in autophagy regulation via lipogenesis and lipid rafts-coupled AKT-FOXO1 signaling pathway

Tan, S.-H., Shui, G., Zhou, J., Shi, Y. P., Huang, J., Xia, D., Wenk, M. R., & Shen, H. (2013) · Autophagy · doi:10.4161/auto.27003 · Cited by 63

Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma

Yen, C.-J., Izzo, J. G., Lee, D., Guha, S., Wei, Y., Wu, T., Chen, C., Kuo, H.-P., Hsu, J.-M., Sun, H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5460 · Cited by 63

Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids

Shen, W., Boyle, D. W., Wisniowski, P., Bade, A., & Liechty, E. A. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06080 · Cited by 62

Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb

Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C., & Blenis, J. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00506-2 · Cited by 1,080

Tumour suppressors hamartin and tuberin: intracellular signalling

Krymskaya, V. P. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00040-8 · Cited by 130

Tuberous sclerosis complex and the mTOR pathway

Kim, K. J. (2011)

Hamartin and tuberin: Working together for tumour suppression

Jóźwiak, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21542 · Cited by 87

Kinases meet at TSC

Wu, Y., & Zhou, B. P. (2007) · Cell Research · doi:10.1038/cr.2007.106 · Cited by 13